Dankiewicz Josef, Nielsen Niklas, Linder Adam, Kuiper Michael, Wise Matthew P, Cronberg Tobias, Erlinge David, Gasche Yvan, Harmon Matthew B, Hassager Christian, Horn Janneke, Kjaergaard Jesper, Pellis Tommaso, Stammet Pascal, Undén Johan, Wanscher Michael, Wetterslev Jørn, Åneman Anders, Ullén Susann, Juffermans Nicole P, Friberg Hans
Department of Intensive and Perioperative Care, Skåne University Hospital, Lund, Sweden; Department of Clinical Sciences, Lund University, Getingevägen, 22185 Lund, Sweden.
Department of Clinical Sciences, Lund University, Getingevägen, 22185 Lund, Sweden; Department of Anaesthesiology and Intensive Care, Helsingborg Hospital, Helsingborg, Sweden.
Resuscitation. 2017 Apr;113:70-76. doi: 10.1016/j.resuscitation.2016.12.008. Epub 2016 Dec 16.
It has been suggested that target temperature management (TTM) increases the probability of infectious complications after cardiac arrest. We aimed to compare the incidence of pneumonia, severe sepsis and septic shock after out-of-hospital cardiac arrest (OHCA) in patients with two target temperatures and to describe changes in biomarkers and possible mortality associated with these infectious complications.
Post-hoc analysis of the TTM-trial which randomized patients resuscitated from OHCA to a target temperature of 33°C or 36°C. Prospective data on infectious complications were recorded daily during the ICU-stay. Pneumonia, severe sepsis and septic shock were considered infectious complications. Procalcitonin (PCT) and C-reactive-protein (CRP) levels were measured at 24h, 48h and 72h after cardiac arrest.
There were 939 patients in the modified intention-to-treat population. Five-hundred patients (53%) developed pneumonia, severe sepsis or septic shock which was associated with mortality in multivariate analysis (Hazard ratio [HR] 1.39; 95%CI 1.13-1.70; p=0.001). There was no statistically significant difference in the incidence of infectious complications between temperature groups (sub-distribution hazard ratio [SHR] 0.88; 95%CI 0.75-1.03; p=0.12). PCT and CRP were significantly higher for patients with infections at all times (p<0.001), but there was considerable overlap.
Patients who develop pneumonia, severe sepsis or septic shock after OHCA might have an increased mortality. A target temperature of 33°C after OHCA was not associated with an increased risk of infectious complications compared to a target temperature of 36°C. PCT and CRP are of limited value for diagnosing infectious complications after cardiac arrest.
有人提出,目标温度管理(TTM)会增加心脏骤停后感染性并发症的发生概率。我们旨在比较两种目标温度的院外心脏骤停(OHCA)患者发生肺炎、严重脓毒症和感染性休克的发生率,并描述生物标志物的变化以及与这些感染性并发症相关的可能死亡率。
对TTM试验进行事后分析,该试验将从OHCA复苏的患者随机分为目标温度33°C或36°C组。在重症监护病房(ICU)住院期间,每天记录有关感染性并发症的前瞻性数据。肺炎、严重脓毒症和感染性休克被视为感染性并发症。在心脏骤停后24小时、48小时和72小时测量降钙素原(PCT)和C反应蛋白(CRP)水平。
改良意向性治疗人群中有939例患者。500例患者(53%)发生肺炎、严重脓毒症或感染性休克,在多变量分析中这与死亡率相关(风险比[HR]1.39;95%置信区间1.13 - 1.70;p = 0.001)。温度组之间感染性并发症的发生率无统计学显著差异(亚组分布风险比[SHR]0.88;95%置信区间0.75 - 1.03;p = 0.12)。感染患者的PCT和CRP在所有时间均显著更高(p < 0.001),但有相当大的重叠。
OHCA后发生肺炎、严重脓毒症或感染性休克的患者可能死亡率增加。与目标温度36°C相比,OHCA后目标温度33°C与感染性并发症风险增加无关。PCT和CRP在诊断心脏骤停后感染性并发症方面价值有限。